Janus Henderson Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $710K | Buy |
|
|||||
|
2025
Q2 | $710K | Hold |
|
|||||
|
2025
Q1 | $624K | Hold |
|
|||||
|
2024
Q4 | $596K | Hold |
|
|||||
|
2024
Q3 | $603K | Hold |
|
|||||
|
2024
Q2 | $491K | Sell |
|
|||||
|
2024
Q1 | $407K | Buy |
|
|||||
|
2023
Q4 | $481K | Sell |
|
|||||
|
2023
Q3 | $569K | Buy |
|
|||||
|
2023
Q2 | $566K | Sell |
|
|||||
|
2023
Q1 | $672K | Sell |
|
|||||
|
2022
Q4 | $23.5M | Buy |
|
|||||
|
2022
Q3 | $906K | Buy |
|
|||||
|
2022
Q2 | $380K | Sell |
|
|||||
|
2022
Q1 | $584K | Buy |
|
|||||
|
2021
Q4 | $498K | Buy |
|
|||||
|
2021
Q3 | $257K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $9.76M | Sell |
|
|||||
|
2019
Q4 | $32.5M | Sell |
|
|||||
|
2019
Q3 | $27.3M | Sell |
|
|||||
|
2019
Q2 | $36.4M | Sell |
|
|||||
|
2019
Q1 | $99.8M | Sell |
|
|||||
|
2018
Q4 | $99.3M | Buy |
|
|||||
|
2018
Q3 | $93.5M | Buy |
|
|||||
|
2018
Q2 | $63.6M | Buy |
|
|||||
|
2018
Q1 | $36.5M | Buy |
|
|||||
|
2017
Q4 | $33.1M | Buy |
|
|||||
|
2017
Q3 | $23.8M | Buy |
|